A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025, that will ...
A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025, that will ...
Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.
Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial datasetLeveraging large-scale, ...
Vietnam Investment Review on MSN
Neurophet launches joint study with VHIR on Neurophet AQUA MS for multiple sclerosis
SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, ...
A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem. The program, presented by ...
Longtime runner Annie Saunders didn’t let a 2021 diagnosis of multiple sclerosis sideline her passions. If anything, the 40-year-old Irwin native pushes harder — through weakness and imbalance caused ...
Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results